Author

Fabrizio Andréelli

InsermORCID 0000-0002-1207-3624Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Adaliene Versiani Matos Ferreira· 1 shared Adma Maciel Babêtto· 1 shared Agatha de Assis-FerreiraiD· 1 shared Amanda Oliveira· 1 shared Ana Letícia Malheiros SilveiraiD· 1 shared Barbara I. Cerame· 1 shared Bruce D. HammockiD· 1 shared Bruno FèveiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Adaliene Versiani Matos Ferreira

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PathologybioRxivPreprintOct 5, 2026

A Weight Loss Fibrotic Response in Visceral Fat Is Driven by Defective Lysosome-Dependent Collagenolysis

Clémentine Rebière, Amanda Oliveira, Sébastien Dussaud…·Geneviève Marcelin

This study shows that weight loss fails to reverse visceral fat fibrosis due to impaired collagen degradation, suggesting ECM clearance enhancement as a therapeutic target.

DOI 10.64898/2026.09.29.755405

mouseexperimental assay

𝕏 PostBluesky

Genetic & Genomic MedicineeLifePeer-reviewedAug 3, 2021

EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence

Jérémie Gautheron, Christophe H.P. Morisseau, Wendy K. Chung…·Isabelle Jéru

The paper identifies EPHX1 mutations causing lipoatrophic diabetes through impaired epoxide hydrolysis and increased cellular senescence, with metreleptin therapy showing benefit.

29 citations

humanexperimental assay

𝕏 PostBluesky